T1	Participants 103 121	healthy volunteers
T2	Participants 447 465	healthy volunteers
T3	Participants 611 676	Healthy male and female volunteers aged 18-75 years were included
T4	Participants 531 544	single-center
T5	Participants 678 752	All volunteers received ASA 81 mg once daily for 5 days prior to the study
T6	Participants 767 903	Subjects were eligible for inclusion if they had aspirin reactivity units (ARU, as measured by the VerifyNow ASA assay) of <550 on Day 6
T7	Participants 924 978	pre-screening and a washout period of at least 14 days
